Monteris Medical secures $28M Series E to accelerate minimally invasive neurosurgery growth
Evidence notes
- Monteris Medical announced a $28M Series E equity financing.
- The company said the capital will support technology innovation and broader growth initiatives.
- Monteris positions NeuroBlate as a robotically controlled MRI-guided laser therapy system for brain intervention.
Company context
Develops minimally invasive neurosurgery systems centered on the NeuroBlate platform for MRI-guided laser interstitial thermal therapy in the brain. The company combines robotic control, cooled laser probe technology, software, and treatment-planning workflow to support targeted ablation of brain lesions in adult and pediatric patients.